As of June 30, 2026, SoftMedX Healthcare Limited carries a market capitalization of 645.92M, placing it among publicly traded companies globally. Its enterprise value stands at 620.68M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 645.92M |
| Enterprise Value | 620.68M |
As of June 30, 2026, SoftMedX Healthcare Limited has 107.12M shares outstanding.
| Shares Outstanding | 107.12M |
These figures are as of June 30, 2026.
| PB Ratio | 20.05 |
| P/TBV Ratio | 20.05 |
As of June 30, 2026, SoftMedX Healthcare Limited maintains a current ratio of 2.50, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.50 |
| Quick Ratio | 1.27 |
| Debt / Equity | 3.96 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 20.00 |
As of the close on November 17, 2026, SoftMedX Healthcare Limited's stock has declined approximately 92.03% over the past 52 weeks. The 50-day moving average sits at 0.42, while the 200-day moving average is 3.17.
| 52-Week Price Change | -92.03% |
| 50-Day Moving Average | 0.42 |
| 200-Day Moving Average | 3.17 |
As of June 30, 2026, SoftMedX Healthcare Limited holds 26.51M in cash and equivalents against 1.28M in total debt, resulting in a net debt position of -26.51M. Total book value stands at 32.22M, with working capital of 31.44M providing operational flexibility.
| Cash & Cash Equivalents | 26.51M |
| Total Debt | 1.28M |
| Net Debt | -26.51M |
| Equity (Book Value) | 32.22M |
| Book Value Per Share | 0.30 |
| Working Capital | 31.44M |
SoftMedX Healthcare Limited's most recent stock split took place on May 28, 2026 with a 20:1 split ratio.
| Last Split Date | 5/28/2026 |
| Split Ratio | 20:1 |
Already premium?